Abstract
The blood brain barrier (BBB), maintained primarily by cerebral capillary endothelial cells, protects the brain by limiting the uptake and circulation of drugs1. It has been observed that the BBB is disrupted during brain tumor growth. The fenestrated capillaries allow large molecules, such as protein and blood products, to penetrate through the BBB and be taken up by tumors cells2. As a consequence, certain boron agents for Boron Neutron Capture Therapy (BNCT), such as borocaptate sodium (BSH)3, are able to penetrate the disrupted BBB and enter tumor tissues. The study of BBB disruption by tumor growth will assist in understanding the mechanism of this penetration and provide a background for BSH pharmacokinetics.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bradbury MWB, The concept of a blood-brain barrier. Wiley, Chichester, 1979.
Long DM, Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors. J neuosur. 32: 127–144, 1970.
Soloway AH, Hatanaka H, and Davis MA, Penetration of brain and brain tumor, VII: Tumor-binding sulfhydryl boron compounds. J. Med. Chem. 10: 714–717, 1967.
Weinmann HJ, Brasch RC, Press WR, and Wesbey GE, Characteristics of gadolinium-DTPA complex: A potential NMR contrast agent. AJR, 142: 619–624, 1984.
Brasch RC, Weinmann HJ, Press WR, and Wesbey GE, Contrast-enhanced NMR imaging: Animal studies using gadolinium-DTPA complex. AJR, 142: 625–630, 1984.
Norman AB, Bertram KJ, Thomas SR, Pratt RG, Samaratunga RC, and Sanberg PR, Magnetic resonance imaging of rat brain following in vivo disruption of the cerebral vasculature. Brain Res. Bull. 26 (4): 593–597, 1991.
Tofts PS, and Kermode AG, Measurement of the blood-brain-barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Mag. Reson. Med. 17: 357–367, 1991
Kenney J, Schmiedl U, Maravilla K, Starr F, Graham M, Spence A, and Nelson J, Measurement of blood-brain-barrier permeability in a tumor model using magnetic resonance imaging with gadoliniumDTPA. Mag. Reson. Med. 27: 68–75. 1992.
Schmiedl UP, Kenney J, and Maravilla KR, Kinetics of pathologic blood-brain-harrier permeability in an astrocytic glioma using contrast-enhanced MR. AJNR, 13: 5–14, 1992.
Larsson HBW, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, and Paulson OB. Quantization of blood-brain-barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Mag. Reson. Med. 16: 117–131, 1990.
Wang HZ, Riederer SJ, and Lee JN, Optimizing the precision in T1 relaxation estimation using limited flip angles. Mag Reson. Med. 5: 399–46, 1987.
Fram EK, Herfkens RJ, Johnson GA, Glover GH, Karis JP, Shimakawa A, Perkins TG, and Pelc NJ, Rapid calculation of T 1 using variable flip angle gradient refocused imaging. J. Mag. Reson. Image. 5: 201–8. 1987.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tang, PP.P.Z., Schweizer, M.P., Hadley, J.R., Hendee, S.P., Tippets, R.H., Bradshaw, K.M. (1996). T1 Measurement to Study the Penetration of BNCT Agents Into Canine Tumors Caused by Blood Brain Barrier Damage. In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_77
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9567-7_77
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9569-1
Online ISBN: 978-1-4757-9567-7
eBook Packages: Springer Book Archive